TuHURA Biosciences, Inc. — Quarterly Balance Sheet (NASDAQ:HURA)

Financials

Total revenue 1 0000000 0 Gross profit 1 0000000 0 Operating expenses 2.21 M5.69 M7.02 M9.88 M6.73 M 29.32 M Selling/general/admin expenses 1.96 M1.72 M2.44 M4.95 M1.76 M 10.86 M Research & development 252 K3.98 M4.58 M4.93 M4.97 M 18.45 M Operating income -2.16 M-5.69 M-7.02 M-9.88 M-6.73 M -29.32 M Non-Operating Income, Total 48 K-301.02 K352.65 K352.12 K-372.85 K 30.9 K Interest expense, net of interest capitalized —522.83 K255.12 K1.36 M16.53 K — Non-Operating Income, excl. Interest Expenses 48 K-522.83 K-255.12 K-1.36 M-16.53 K -2.15 M Unusual income/expense —-301.02 K352.65 K352.12 K-372.85 K 30.9 K Pretax income -2.11 M-1.72 M-2.44 M-4.95 M-1.76 M -10.86 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 2.16 M-6 M-6.66 M-9.52 M-7.1 M -29.29 M Discontinued operations ————— — Net income 2.16 M-6 M-6.66 M-9.52 M-7.1 M -29.29 M Dilution adjustment 28 K———— — Preferred dividends 13 K———— — Diluted net income available to common stockholders 2.18 M-6 M-6.67 M-9.53 M-7.1 M -29.29 M Basic earnings per share (Basic EPS) -1.370.16-0.15-0.21-0.14 -0.34 Diluted earnings per share (Diluted EPS) 1.360.16-0.15-0.21-0.14 -0.34 Average basic shares outstanding 1.59 M18.66 M43.4 M44.98 M46.24 M 153.29 M Diluted shares outstanding 1.59 M18.66 M43.4 M44.98 M46.24 M 153.29 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 17 K17.64 K14.06 K13.37 K21.29 K 66.36 K